FR940919-0-00025 FR940919-0-00005 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 5 Delegations of Authority and Organization; Counterfeit Drugs Enforcement Activities AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the regulations for delegations of authority relating to enforcement activities. The amendment designates FDA officers or employees who have been issued official credential FDA&hyph;200D to administer oaths and affirmations for use in any prosecution or proceeding under or in the enforcement of any law enforced by FDA. EFFECTIVE DATE: September 19, 1994. FOR FURTHER INFORMATION CONTACT: John L. Paolino, Jr., Office of Criminal Investigations (HFC&hyph;300), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;294&hyph;4030, or Ellen Rawlings, Division of Management Systems and Policy (HFA&hyph;340), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4976. SUPPLEMENTARY INFORMATION: FDA is amending the regulations for delegations of authority for ยง5.35 Enforcement activities (21 CFR 5.35) by designating FDA officers and employees who have been issued official credential FDA&hyph;200D, Special Authority for Criminal Investigators, the authority to administer oaths and affirmations for use in any prosecution or proceeding under or in the enforcement of any law enforced by FDA. This authority is the same as that delegated to holders of FDA&hyph;200A and FDA&hyph;200B credentials. This authority may not be redelegated. List of Subjects in 21 CFR Part 5 Authority delegations (Government agencies), Imports, Organization and functions (Government agencies). Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 5 is amended as follows: PART 5_DELEGATIONS OF AUTHORITY AND ORGANIZATION 1. The authority citation for 21 CFR part 5 continues to read as follows: Authority: 5 U.S.C. 504, 552, App. 2; 7 U.S.C. 138a, 2271; 15 U.S.C. 638, 1261&hyph;1282, 3701&hyph;3711a; secs. 2&hyph;12 of the Fair Packaging and Labeling Act (15 U.S.C. 1451&hyph;1461); 21 U.S.C. 41&hyph;50, 61&hyph;63, 141&hyph;149, 467f, 679(b), 801&hyph;886, 1031&hyph;1309; secs. 201&hyph;903 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321&hyph;394); 35 U.S.C. 156; secs. 301, 302, 303, 307, 310, 311, 351, 352, 361, 362, 1701&hyph;1706, 2101, 2125, 2127, 2128 of the Public Health Service Act (42 U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 264, 265, 300u&hyph;300u&hyph;5, 300aa&hyph;1, 300aa&hyph;25, 300aa&hyph;27, 300aa&hyph;28); 42 U.S.C. 1395y, 3246b, 4332, 4831(a), 10007&hyph;10008; E.O. 11490, 11921, and 12591; secs. 312, 313, 314 of the National Childhood Vaccine Injury Act of 1986, Pub. L. 99&hyph;660 (42 U.S.C. 300aa&hyph;1 note). 2. Section 5.35 is amended by adding new paragraph (b)(3) to read as follows: ยง5.35 Enforcement activities. * * * * * (b)(3) To administer oaths and affirmations under section 1 of the act of January 31, 1925 (Ch. 124, 43 Stat. 803); sections 12 to 15 of Reorganization Plan No. IV, effective June 30, 1940; and Reorganization Plan No. 1 of 1953, effective April 11, 1953. * * * * * Dated: September 9, 1994. Gary Dykstra, Acting Associate Commissioner for Regulatory Affairs. [FR Doc. 94&hyph;23036 Filed 9&hyph;16&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
